These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 38729321

  • 1. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F, Zhao Y, Wang G, Zhao M, Hong X, Ye Z, Dong F, Li W, Deng Q.
    Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
    [Abstract] [Full Text] [Related]

  • 2. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
    Jiang Y, Wang K, Lu X, Wang Y, Chen J.
    Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
    [Abstract] [Full Text] [Related]

  • 3. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ, Zhu HC, Du Y, Zhao HC, Wang L.
    Technol Cancer Res Treat; 2022 Dec; 21():15330338221077803. PubMed ID: 35167383
    [Abstract] [Full Text] [Related]

  • 4. Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma.
    Dong FL, Xu ZZ, Wang YQ, Li T, Wang X, Li J.
    J Nanobiotechnology; 2024 May 30; 22(1):298. PubMed ID: 38811968
    [Abstract] [Full Text] [Related]

  • 5. Research on the mechanism of exosomes from different sources influencing the progression of lung cancer.
    Mao G, Liu J.
    Environ Toxicol; 2024 Aug 30; 39(8):4231-4248. PubMed ID: 38760988
    [Abstract] [Full Text] [Related]

  • 6. Identification of SLC7A11-AS1/SLC7A11 pair as a ferroptosis-related therapeutic target for hepatocellular carcinoma.
    Yuan X, Wang Y, Jiao S, Gao H, Zhang M, Wang X, Zhou X, Wu C, Bao J.
    J Cell Mol Med; 2024 Jul 30; 28(13):e18496. PubMed ID: 38984939
    [Abstract] [Full Text] [Related]

  • 7. POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axis.
    Li J, Li PT, Wu W, Ding BN, Wen YG, Cai HL, Liu SX, Hong T, Zhang JF, Zhou JD, Qian LY, Du J.
    Epigenomics; 2024 Feb 30; 16(4):215-231. PubMed ID: 38318853
    [Abstract] [Full Text] [Related]

  • 8. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
    Xu Q, Zhao T, Han H, Fan J, Xie W.
    Thorac Cancer; 2023 Feb 30; 14(5):450-461. PubMed ID: 36541122
    [Abstract] [Full Text] [Related]

  • 9. FAP positive cancer-associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1-AS1.
    Zhou X, Tong Y, Yu C, Pu J, Zhu W, Zhou Y, Wang Y, Xiong Y, Sun X.
    Mol Carcinog; 2024 Oct 30; 63(10):1922-1937. PubMed ID: 38934786
    [Abstract] [Full Text] [Related]

  • 10. Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686.
    Chai Y, Wu HT, Liang CD, You CY, Xie MX, Xiao SW.
    Int J Nanomedicine; 2020 Oct 30; 15():8863-8872. PubMed ID: 33204092
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
    Chen H, Wang L, Liu J, Wan Z, Zhou L, Liao H, Wan R.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2223377. PubMed ID: 37370246
    [Abstract] [Full Text] [Related]

  • 13. Cancer-associated fibroblasts derived exosomal LINC01833 promotes the occurrence of non-small cell lung cancer through miR-335-5p -VAPA axis.
    Chen J, Sun JJ, Ma YW, Zhu MQ, Hu J, Lu QJ, Cai ZG.
    J Biochem Mol Toxicol; 2024 Sep 31; 38(9):e23769. PubMed ID: 39152098
    [Abstract] [Full Text] [Related]

  • 14. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z, Lin G, Hong Y, Weng L, Zhu K, Zhuang W.
    Environ Toxicol; 2024 Jul 31; 39(7):4035-4046. PubMed ID: 38642004
    [Abstract] [Full Text] [Related]

  • 15. METTL3-modified lncRNA DSCAM-AS1 promotes breast cancer progression through inhibiting ferroptosis.
    Yan Z, Liang Z, Luo K, Yu L, Chen C, Yu M, Guo X, Li M.
    J Bioenerg Biomembr; 2024 Aug 31; 56(4):451-459. PubMed ID: 38833042
    [Abstract] [Full Text] [Related]

  • 16. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
    Mao G, Mu Z, Wu DA.
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov 10; 53(11):1484-1494. PubMed ID: 34605863
    [Abstract] [Full Text] [Related]

  • 17. METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification.
    Ren H, Wang M, Ma X, An L, Guo Y, Ma H.
    Biol Direct; 2024 Aug 19; 19(1):68. PubMed ID: 39160584
    [Abstract] [Full Text] [Related]

  • 18. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1.
    Zhao J, Yang S, Lv C, Liu Y.
    Am J Physiol Cell Physiol; 2023 May 01; 324(5):C1039-C1052. PubMed ID: 36878845
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.
    Cai L, Hu X, Ye L, Bai P, Jie Y, Shu K.
    Bioengineered; 2022 Apr 01; 13(4):8226-8239. PubMed ID: 35311457
    [Abstract] [Full Text] [Related]

  • 20. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
    Zhang Y, Guo S, Wang S, Li X, Hou D, Li H, Wang L, Xu Y, Ma B, Wang H, Jiang X.
    Ecotoxicol Environ Saf; 2021 Sep 01; 220():112376. PubMed ID: 34051661
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.